Crosstalk between Mast Cells and Lung Fibroblasts Is Modified by Alveolar Extracellular Matrix and Influences Epithelial Migration.
A549 Cells
Cell Communication
/ physiology
Cell Movement
/ physiology
Cells, Cultured
Coculture Techniques
Epithelial Cells
/ cytology
Extracellular Matrix
/ physiology
Fibroblasts
/ cytology
Hepatocyte Growth Factor
/ metabolism
Humans
Idiopathic Pulmonary Fibrosis
/ metabolism
Interleukin-6
/ metabolism
Lung
/ cytology
Mast Cells
/ cytology
Microscopy, Electron, Scanning
Vascular Endothelial Growth Factor A
/ metabolism
IL-6
epithelial cells
extracellular matrix
hepatocyte growth factor
idiopathic pulmonary fibrosis
lung fibroblasts
mast cells
tryptase
vascular endothelial growth factor
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
06 Jan 2021
06 Jan 2021
Historique:
received:
23
11
2020
revised:
29
12
2020
accepted:
04
01
2021
entrez:
9
1
2021
pubmed:
10
1
2021
medline:
14
9
2021
Statut:
epublish
Résumé
Mast cells play an important role in asthma, however, the interactions between mast cells, fibroblasts and epithelial cells in idiopathic pulmonary fibrosis (IPF) are less known. The objectives were to investigate the effect of mast cells on fibroblast activity and migration of epithelial cells. Lung fibroblasts from IPF patients and healthy individuals were co-cultured with LAD2 mast cells or stimulated with the proteases tryptase and chymase. Human lung fibroblasts and mast cells were cultured on cell culture plastic plates or decellularized human lung tissue (scaffolds) to create a more physiological milieu by providing an alveolar extracellular matrix. Released mediators were analyzed and evaluated for effects on epithelial cell migration. Tryptase increased vascular endothelial growth factor (VEGF) release from fibroblasts, whereas co-culture with mast cells increased IL-6 and hepatocyte growth factor (HGF). Culture in scaffolds increased the release of VEGF compared to culture on plastic. Migration of epithelial cells was reduced by IL-6, while HGF and conditioned media from scaffold cultures promoted migration. In conclusion, mast cells and tryptase increased fibroblast release of mediators that influenced epithelial migration. These data indicate a role of mast cells and tryptase in the interplay between fibroblasts, epithelial cells and the alveolar extracellular matrix in health and lung disease.
Identifiants
pubmed: 33419174
pii: ijms22020506
doi: 10.3390/ijms22020506
pmc: PMC7825515
pii:
doi:
Substances chimiques
Interleukin-6
0
Vascular Endothelial Growth Factor A
0
Hepatocyte Growth Factor
67256-21-7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Vetenskapsrådet
ID : 2016-01190
Organisme : Vetenskapsrådet
ID : 3R project 2014-2016
Organisme : Crafoordska Stiftelsen
ID : -
Organisme : Greta and John Kock Foundation
ID : -
Organisme : Hjärt-Lungfonden
ID : -
Organisme : The Royal Physiographic Society in Lund
ID : -
Organisme : Alfred Österlunds Stiftelse
ID : -
Organisme : Crafoordska Stiftelsen
ID : -
Organisme : The Consul Thure Bergh Foundation
ID : -
Organisme : ALF Grants Region Skåne
ID : -
Organisme : Lund University Medical Faculty Foundation
ID : -
Organisme : Stiftelsen för Strategisk Forskning
ID : -
Organisme : Evy and Gunnar Sandberg Foundation
ID : -
Références
Respir Res. 2010 May 11;11:55
pubmed: 20459817
Int J Mol Sci. 2018 Apr 24;19(5):
pubmed: 29695053
Am J Respir Crit Care Med. 2017 Aug 15;196(4):479-493
pubmed: 28661183
Respir Res. 2011 Oct 20;12:139
pubmed: 22014187
Pulm Pharmacol Ther. 2014 Dec;29(2):144-55
pubmed: 25316209
Am J Respir Crit Care Med. 2004 Nov 15;170(10):1049-56
pubmed: 15256392
Am J Physiol Lung Cell Mol Physiol. 2017 Dec 1;313(6):L1164-L1173
pubmed: 28860144
Physiol Rep. 2016 Mar;4(5):
pubmed: 26997628
Int J Mol Sci. 2019 Aug 17;20(16):
pubmed: 31426504
J Exp Med. 2011 Jul 4;208(7):1339-50
pubmed: 21727191
Thorax. 2010 Aug;65(8):670-6
pubmed: 20685740
Lab Invest. 1979 Jun;40(6):717-34
pubmed: 449278
Physiol Rep. 2016 Aug;4(15):
pubmed: 27482070
Lancet Respir Med. 2019 Sep;7(9):771-779
pubmed: 31326319
J Exp Med. 2011 Jul 4;208(7):1459-71
pubmed: 21708929
Am J Pathol. 2013 Jun;182(6):2094-108
pubmed: 23562441
JCI Insight. 2017 Aug 17;2(16):
pubmed: 28814671
Respir Res. 2020 Feb 18;21(1):56
pubmed: 32070329
Sci Rep. 2017 Mar 06;7:43829
pubmed: 28262742
Respir Res. 2006 Jan 23;7:11
pubmed: 16430780
Sci Rep. 2018 Jan 31;8(1):1927
pubmed: 29386571
Int J Mol Sci. 2019 Nov 06;20(22):
pubmed: 31698677
Front Pharmacol. 2014 Jan 21;4:174
pubmed: 24478701
Proc Am Thorac Soc. 2012 Jul;9(3):158-63
pubmed: 22802291
J Innate Immun. 2020;12(5):357-372
pubmed: 32498069
Kidney Int. 2013 Aug;84(2):317-26
pubmed: 23515052
Sci Rep. 2018 Apr 3;8(1):5409
pubmed: 29615673
Immunology. 2000 Mar;99(3):435-9
pubmed: 10712674
PLoS Genet. 2013;9(2):e1003228
pubmed: 23459311
Eur Respir J. 2017 Jul 5;50(1):
pubmed: 28679607
Immunol Rev. 2018 Mar;282(1):121-150
pubmed: 29431212
J Immunol. 2002 Jul 15;169(2):1014-20
pubmed: 12097409
Physiol Rev. 1997 Oct;77(4):1033-79
pubmed: 9354811
Am J Respir Cell Mol Biol. 2016 Sep;55(3):309-22
pubmed: 27149613
Cell Commun Signal. 2018 Sep 15;16(1):59
pubmed: 30219079
J Am Soc Nephrol. 2001 Aug;12(8):1668-76
pubmed: 11461939
J Proteomics. 2018 Oct 30;189:23-33
pubmed: 29501846
Thorax. 2019 May;74(5):455-465
pubmed: 30808717
Histopathology. 2011 Jun;58(7):1096-106
pubmed: 21707711
J Immunol. 1997 Mar 1;158(5):2310-7
pubmed: 9036979